The role of N-glycans in colorectal cancer progression: Potential biomarkers and therapeutic applications

77Citations
Citations of this article
106Readers
Mendeley users who have this article in their library.

Abstract

Changes in glycosylation, which is one of the most common protein post-translational modifications, are considered to be a hallmark of cancer. N-glycans can modulate cell migration, cell-cell adhesion, cell signaling, growth and metastasis. The colorectal cancer (CRC) is a leading cause of cancer-related mortality and the correlation between CRC progression and changes in the pattern of expression of N-glycans is being considered in the search for new biomarkers. Here, we review the role of N-glycans in CRC cell biology. The perspectives on emerging N-glycan-related anticancer therapies, along with new insights and challenges, are also discussed.

Cite

CITATION STYLE

APA

De Freitas-Junior, J. C. M., & Morgado-Díaz, J. A. (2016, April 12). The role of N-glycans in colorectal cancer progression: Potential biomarkers and therapeutic applications. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.6283

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free